Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing and delivering innovative human therapeutics – focused on areas of high unmet medical need. Leveraging its biologics expertise, Amgen has been a biotechnology pioneer since 1980. Today it is one of the world’s leading independent biotechnology companies, reaching millions of patients globally.

Amgen has more than 500 staff in the UK and Ireland, working across Commercial and Research & Development organisations. The UK & Ireland commercial Affiliate operates from offices in Cambridge, Uxbridge and Dublin. In R&D, Cambridge, along with Amgen’s office in Uxbridge, supports clinical development, regulatory affairs and other specialist R&D functions at local, European and global levels – including biostatistical sciences, safety, medical and quality/compliance.

Cambridge Science Park was home to Amgen’s first UK office more than 25 years ago and has been at the forefront of Amgen’s European R&D organisation ever since. Today, Amgen’s UK R&D presence is one of the company’s largest hubs outside its global headquarters in Thousand Oaks, California.

The UK & Ireland Affiliate is responsible for working with the health services across the UK and in the Republic of Ireland to support the company’s portfolio of medicines and progress its ultimate mission – to serve patients.

www.amgen.com
www.amgen.co.uk

Address

Amgen
240, Cambridge Science Park
Milton Road, Cambridge
Cambridgeshire, United Kingdom
CB4 0WD
Telephone: +44 (0)1223 420305
Fax: +44 (0)1223 426078
Email:
Web: http://www.amgen.com